Filing Flows › Syndax Pharmaceuticals (SNDX) › Product revenue
Syndax Pharmaceuticals (SNDX) Product revenue by quarter
Syndax Pharmaceuticals' Product revenue was $60.7M in Q3 2026 (third quarter 2026), +11% from Q2 2026. Over the last 5 quarters it ranged from $28.6M (Q2 2025) to $60.7M (Q3 2026).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $60.7M | +11% | +90% |
| Q2 2026 | $54.7M | +12% | +91% |
| Q1 2026 | $48.9M | +53% | — |
| Q3 2025 | $32.0M | +12% | — |
| Q2 2025 | $28.6M | — | — |
Q3 2026 at a glance
Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Syndax Pharmaceuticals' Product revenue?
Syndax Pharmaceuticals' Product revenue was $60.7M in Q3 2026 (third quarter 2026), +11% from Q2 2026.
How has Syndax Pharmaceuticals' Product revenue changed?
Over the last 5 quarters it ranged from $28.6M (Q2 2025) to $60.7M (Q3 2026).
Q3 2026 results → · How Syndax Pharmaceuticals makes money →